. 1971 Oct;193(2):340-56.

Aspects of the gastric acid antisecretory activity of 3,3-dimethyl-1-(3-methylaminopropyl)-1-phenylphthalan: a blocker of norepinephrine uptake

W Lippmann. Arch Int Pharmacodyn Ther. 1971 Oct.

. 1971 Oct;193(2):340-56.

No abstract available

Similar articles

Reduction of gastric acid secretion and ulcer formation by 3,3-dimethyl-1-(3-methylaminopropyl)-1-phenylphthalan (Lu 3-010); an inhibitor of noradrenaline uptake.
Lippmann W. Lippmann W. J Pharm Pharmacol. 1970 Aug;22(8):568-73. doi: 10.1111/j.2042-7158.1970.tb10572.x. J Pharm Pharmacol. 1970. PMID: 4394529 No abstract available.
Antigastric acid secretory activities of N,N'-bis (1-naphthylmethyl)-1,4-cyclohexane bis (methylamine) dihydrochloride and structurally-related compounds in the rat.
Lippmann W. Lippmann W. Arch Int Pharmacodyn Ther. 1970 Nov;188(1):28-43. Arch Int Pharmacodyn Ther. 1970. PMID: 4394966 No abstract available.
Blocking H 3 -Norepinephrine uptake and some guanethidine-induced effects with tricyclic psychotherapeutic drugs.
Koe BK, Constantine JW. Koe BK, et al. Arch Int Pharmacodyn Ther. 1972 Jan;195(1):71-80. Arch Int Pharmacodyn Ther. 1972. PMID: 5010834 No abstract available.
Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16, 16-dimethyl PGE2. Intravenous, oral and intrajejunal administration.
Robert A, Schultz JR, Nezamis JE, Lancaster C. Robert A, et al. Gastroenterology. 1976 Mar;70(3):359-70. Gastroenterology. 1976. PMID: 174967 Review.
The spectrum of inhibition of gastric acid secretion.
Wyllie JH. Wyllie JH. Surg Annu. 1979;11:207-24. Surg Annu. 1979. PMID: 41329 Review. No abstract available.

Oral anti-ulcer activity of a synthetic prostaglandin analogue (9-oxoprostanoic acid: AY-22,469).
Lippmann W, Seethaler K. Lippmann W, et al. Experientia. 1973 Aug 15;29(8):993-5. doi: 10.1007/BF01930424. Experientia. 1973. PMID: 4733332 No abstract available.